Hyperlipidemia
Hyperlipidemia refers to high blood lipid levels, which is a systemic disease caused by abnormal fat metabolism or operation, making plasma lipids higher than normal. It refers to high cholesterol or triglycerides in the blood, or low high-density lipoprotein cholesterol. Modern medicine calls it dyslipidemia. Hyperlipidemia can be divided into primary and secondary types. The former is related to the environment and family inheritance. The latter is caused by diabetes, hypothyroidism, obesity, pancreatitis, etc. It is particularly common in middle-aged and elderly people. According to statistics, the number of people with hyperlipidemia has reached 200 million. In addition, since there are no obvious symptoms in the early stage of hyperlipidemia, it is easy to be ignored by patients. It all happens unconsciously and can only be discovered during health examinations. Therefore, it is also called: the silent killer.
Related Drugs
Niacin Tablets
Indication: 1. Used to prevent and treat niacin deficiency diseases such as pellagra. Also used as a vasodilator to treat hyperlipidemia. 2. Patients who strictly control or select their diet, or receive parenteral nutrition, who lose weight suddenly due to malnutrition, those who are pregnant or breastfeeding, those who take isoniazid, those who are severely addicted to smoking, alcohol, or drugs, all have increased niacin requirements.
Manufacturer:
Sinopharm Group Tongjitang(Guizhou)Pharmaceutical Co., Ltd.
Niacin Tablets
Indication: 1. Used to prevent and treat niacin deficiency diseases such as pellagra. Also used as a vasodilator to treat hyperlipidemia. 2. Patients who strictly control or select their diet, or receive parenteral nutrition, who lose weight suddenly due to malnutrition, those who are pregnant or breastfeeding, those who take isoniazid, those who are severely addicted to smoking, alcohol, or drugs, all have increased niacin requirements.
Manufacturer:
Linfen Baozhu Pharmaceutical Co., Ltd.
Niacin Tablets
Indication: 1. Used to prevent and treat niacin deficiency diseases such as pellagra. Also used as a vasodilator to treat hyperlipidemia. 2. Patients who strictly control or select their diet, or receive parenteral nutrition, who lose weight suddenly due to malnutrition, those who are pregnant or breastfeeding, those who take isoniazid, those who are severely addicted to smoking, alcohol, or drugs, all have increased niacin requirements.
Lovastatin Tablets
Indication: Used to treat hypercholesterolemia and combined hyperlipidemia.
Manufacturer:
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
Lovastatin Tablets
Indication: Used to treat hypercholesterolemia and combined hyperlipidemia.
Manufacturer:
North China Pharmaceutical Company.Ltd
Fluvastatin Sodium Capsules
Indication: Hyperlipidemia that cannot be completely controlled by diet.
Manufacturer:
Beijing Novartis Pharma Co., Ltd.
Pravastatin Sodium Tablets
Indication: Hyperlipidemia, familial hypercholesterolemia.
Manufacturer:
Daiichi Sankyo Pharmaceutical (SHANGHAI) Co., Ltd.
Pravastatin Sodium Tablets
Indication: Hyperlipidemia, familial hypercholesterolemia.
Manufacturer:
Daiichi Sankyo Pharmaceutical (SHANGHAI) Co., Ltd.
Aluminum Clofibrate Tablets
Indication: This product is used to treat hyperlipidemia in adults who have not responded well to dietary control therapy. Its triglyceride-lowering effect is more obvious than its cholesterol-lowering effect, and is effective for hyperlipoproteinemia of type III, IV, and V. However, this product cannot completely replace dietary control therapy and can only be used as an auxiliary treatment based on dietary control. In addition, clofibrate is currently used clinically for atherosclerosis and its secondary diseases, such as coronary artery disease, cerebrovascular disease, peripheral vascular disease, and arterial disease caused by diabetes.
Manufacturer:
Shandong Lukang Group Saite Co., Ltd.
Rosuvastatin Calcium Tablets
Indication: 1. This product is suitable for primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia) or mixed dyslipidemia (type IIb) whose dyslipidemia cannot be properly controlled by diet control and other non-drug treatments (such as exercise therapy, weight loss). 2. This product is also suitable for patients with homozygous familial hypercholesterolemia as an adjuvant treatment for diet control and other lipid-lowering measures (such as LDL removal therapy), or when these methods are not applicable.